<DOC>
	<DOC>NCT01562639</DOC>
	<brief_summary>The purpose of this study is to collect following data in patients given Nexium capsule (Nexium) in usual post-marketing use as the maintenance therapy for repeatedly recurring/relapsing reflux oesophagitis.</brief_summary>
	<brief_title>Nexium Capsules RE Maintenance Specific Clinical Experience Investigation</brief_title>
	<detailed_description>Nexium capsules Specific Clinical Experience Investigation for Maintenance Therapy for Repeatedly Recurring/Relapsing Reflux Oesophagitis</detailed_description>
	<mesh_term>Esophagitis</mesh_term>
	<mesh_term>Esophagitis, Peptic</mesh_term>
	<mesh_term>Recurrence</mesh_term>
	<mesh_term>Esomeprazole</mesh_term>
	<criteria>Patients with repeatedly recurring/relapsing reflux oesophagitis who will be given Nexium for the first time as a maintenance therapy. Patients having reflux oesophagitis when Nexium is started (Grade A, Grade B, Grade C or Grade D of Los Angeles Classification (Hoshihara's modification) on endoscopy) Patients having previous history of maintenance therapy for repeatedly recurring/ relapsing reflux oesophagitis</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>maintenance therapy,</keyword>
	<keyword>repeatedly recurring,</keyword>
	<keyword>relapsing reflux oesophagitis,</keyword>
	<keyword>Nexium</keyword>
</DOC>